Clinical News

What is the state of OTC contraception, what’s next for IUDs, and why are so many transgender people denied care?

A recent study examined the effects that different work environments can have on adults with asthma.

A majority of patients say that taking cannabis helps them with chronic pain management and other conditions.

Some patients with PAH need to travel long distances, which may impact their access to quality care providers.

A higher dose of the carbonic anhydrase inhibitor does not seem to provide any additional improvements.

The atrial fibrillation drug, asundexian, may provide protection from thrombotic events without a corresponding increase in bleeding risk.

Balanced products showed greater improvements compared to either CBD-dominant or THC-dominant products.

The specialty drug pipeline is projected to grow by 8% each year through 2025.

Common treatments for acne are known to be unsafe for pregnant women, but alternative treatments exist that are safe for use; however, actual treatment patterns within this patient population are unclear.

Inhaled corticosteroids were observed to be associated with increases in rates of pneumonia and tuberculosis, according to a recent study.

A recent clinical trial showed positive results from the selective neurokinin-1,3 receptor antagonist elinzanetant (Bayer) against menopausal vasomotor symptoms.

Though the Omicron variant caused the most symptoms in pediatric patients, there were no differences in adverse outcomes by COVID-19 variant.

The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.

A recent study found that Medicare patients used low-benefit options more frequently than high-benefit options.

Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.

IBS in pediatric patients has not been studied much, but new data reveals a possible treatment.

STAQ, a 503B outsourcing facility, started making desmopressin nasal spray after Ferring Pharmaceuticals suspended production nearly three years ago.

Combining the two drugs appears more likely to reduce risk of early COVID-19 symptoms worsening than taking either one on its own.

A recent study showed a link between menopause and increased glaucoma risk, with estrogen-based treatment being a possible solution.

Tirzepatide was associated with a greater reduction in hemoglobin A1c and body weight when compared to semaglutide. But with a current list price of $1,023 for a one-month supply, is tirzepatide (Mounjaro; Lilly) worth it?

Researchers of a new study investigated what's causing vaccine hesitancy, and why individuals are feeling vaccine fatigue.

A new study from JAPHA explores the link between OUD and social factors.

Data reveal 50% of meningitis vaccination appointments were delayed or canceled amid the COVID-19 pandemic, leading authors of a survey to highlight the need for “urgent action” to maintain routine vaccination levels among children.

Approximately 8000 to 9000 U.S. patients would be eligible for this combination, intended for patients with locally advanced or metastatic urothelial cancer (la/mUC).

Masking, social distancing, and school closures all contributed to children being exposed to fewer environmental triggers of asthma.

In a recent trial, investigators found increased rates of screening when human papillomavirus (HPV) self-sampling kits were mailed to participants, and that this process costs less than usual care.

However, the researches make clear that their findings should not be construed as an endorsement of irresponsible or liberal opioid use.

The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.

The risk of developing breast cancer was greater in women who are currently using or recently used progestogen-only contraceptives, a recent study showed.

Efanesoctocog alfa is a recombinant factor VIII therapy with once-a-week dosing.